1. Agid Y, Javoy-Agid F, Ruberg M (1987) Biochemistry of neurotransmitters in Parkinson’s disease. In: Marsden CD, Fahn S (eds) Movement disorders 2. Butterworth, London, pp 166–230
2. Ambrozi L, Danielczyk W (1988) Die Behandlung zerebraler FunktionsstÖrungen mit Memantine bei psychogeriatrischen Patienten — Ergebnisse einer Phase-II-Doppelblindstudie. Pharmacopsychiatry 21: 144–146
3. Andersen J, Aabro E, Gulmann N, Hjelmisted A, Pedersen HE (1980) Anti-depressive treatment in Parkinson’s disease: a controlled trial of the effect of nortriptyline in patients with PD treated with L-dopa. Acta Neurol Scand 62: 210–219
4. Baldessarini RJ, Marsh E (1990) Fluoxetine and side effects [Letter]. Arch Gen Psychiatry 47: 191–192
5. Baldessarini RJ, Frankenburg FR (1991) Clozapine: a novel antipsychotic agent. N Engl J Med 324: 740–754